Phase I study of erlotinib and hydroxychloroquine in non-small cell lung cancer

被引：0
|
作者：
Sequist, Lecia, V [1 ]
Sharma, Sreenath, V [1 ]
Supko, Jeffrey G. [1 ]
Neal, Joel W. [1 ]
Fidias, Panos [1 ]
Temel, Jennifer [1 ]
Heist, Suk Rebecca [1 ]
Shaw, Alice T. [1 ]
Engelman, Jeffrey A. [1 ]
Settleman, Jeffrey E. [1 ]
Lynch, Thomas J. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S712 / S713
页数：2
相关论文
共 50 条
  • [31] Biomarker analyses from a phase I study of pertuzumab combined with erlotinib in patients (pts) with non-small cell lung cancer (NSCLC)
    Felip, E.
    Ranson, M.
    Cedres, S.
    Brewster, M.
    Mcnally, V.
    Venturi, M.
    Passioukov, A.
    Ross, G.
    Galdermans, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] Weekly high-dose erlotinib in patients with non-small cell lung cancer (NSCLC): A phase I/II study.
    Milton, DT
    Miller, VA
    Azzoli, CG
    Dunne, M
    Gomez, JE
    Heelan, R
    Krug, LM
    Ramies, D
    Rizvi, NA
    Kris, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 637S - 637S
  • [33] Phase II study of erlotinib in advanced non-small cell lung cancer patients with leptomeningeal metastasis.
    Nosaki, Kaname
    Shiraishi, Yoshimasa
    Hirai, Fumihiko
    Harada, Taishi
    Himeji, Daisuke
    Kitazaki, Takeshi
    Ebi, Noriyuki
    Hamada, Akinobu
    Yamanaka, Takeharu
    Takenoyama, Mitsuhiro
    Sugio, Kenji
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Expression of phase I enzymes in non-small cell lung cancer
    Oyama, Tsunehiro
    Sugio, Kenji
    Uramoto, Hidetaka
    Hanagiri, Takeshi
    Nozoe, Tadahiro
    Sugaya, Masakazu
    Ono, Kenji
    Nakata, Shoji
    Ichiki, Yoshinobu
    So, Tetsuya
    Mizukami, Makiko
    Fukuyama, Takashi
    Baba, Tetsuro
    Isse, Toyohi
    Kawamoto, Toshihiro
    Yasumoto, Kosei
    CANCER RESEARCH, 2006, 66 (08)
  • [35] Erlotinib in First-line Therapy for Non-small Cell Lung Cancer: A Prospective Phase II Study
    Choi, Dae Ro
    Lee, Dae Ho
    Choi, Chang-Min
    Kim, Sang-We
    Suh, Cheolwon
    Lee, Jung-Shin
    ANTICANCER RESEARCH, 2011, 31 (10) : 3457 - 3462
  • [36] Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer
    Kaburagi, Takayuki
    Satoh, Hiroaki
    Hayashihara, Kenji
    Endo, Takeshi
    Hizawa, Nobuyuki
    Kurishima, Koichi
    Nishimura, Yoshihiro
    Hashimoto, Toshio
    Nakamura, Hiroyuki
    Kishi, Koji
    Inagaki, Masaharu
    Nawa, Takeshi
    Ichimura, Hideo
    Ishikawa, Hiroichi
    Kagohashi, Katsunori
    Fukuoka, Toshihiko
    Shinohara, Yoko
    Kamiyama, Koichi
    Sato, Yukio
    Sakai, Mitsuaki
    Matsumura, Takeshi
    Uchiumi, Keiko
    Furukawa, Kinya
    ONCOLOGY LETTERS, 2013, 5 (02) : 435 - 439
  • [37] Phase II study of erlotinib for acquired resistance to gefitinib in patients with advanced non-small cell lung cancer
    Horiike, A.
    Yamamoto, N.
    Tanaka, H.
    Yanagitani, N.
    Kudo, K.
    Ohyanagi, F.
    Naito, T.
    Murakami, H.
    Horai, T.
    Nishio, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [38] Phase II Study of Erlotinib for Acquired Resistance to Gefitinib in Patients with Advanced Non-small Cell Lung Cancer
    Horiike, Atsushi
    Yamamoto, Nobuyuki
    Tanaka, Hisashi
    Yanagitani, Noriko
    Kudo, Keita
    Ohyanagi, Fumiyoshi
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Horai, Takeshi
    Nishio, Makoto
    ANTICANCER RESEARCH, 2014, 34 (04) : 1975 - 1981
  • [39] Preoperative erlotinib in clinical stage I and II non-small cell lung cancer.
    Port, J. L.
    Yankelevitz, D.
    Lee, P. C.
    Spinelli, C.
    Altorki, N. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer
    Garon, Edward B.
    Siegfried, Jill M.
    Stabile, Laura P.
    Young, Patricia A.
    Marquez-Garban, Diana C.
    Park, David J.
    Patel, Ravi
    Hu, Eddie H.
    Sadeghi, Saeed
    Parikh, Rupesh J.
    Reckamp, Karen L.
    Adams, Brad
    Elashoff, Robert M.
    Elashoff, David
    Grogan, Tristan
    Wang, He-Jing
    Dacic, Sanja
    Brennan, Meghan
    Valdes, Yacgley
    Davenport, Simon
    Dubinett, Steven M.
    Press, Michael F.
    Slamon, Dennis J.
    Pietras, Richard J.
    LUNG CANCER, 2018, 123 : 91 - 98
12345